findmyKOL

Andrew Schimel, MD

Basic profile

Florida International University

ORCIDNone on fileNPI↗
✓ Full record
RegionMiami, FL · SoutheastSpecialtyOphthalmologyFocusOphthalmology
Active KOLfindmyKOL type: NationalLatest publication2024Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Andrew Schimel is an Ophthalmology physician affiliated with Florida International University. OpenAlex indexes 25 publications with 727 citations (h-index 12).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
25publications

Distinct works indexed by OpenAlex.

727citations

Total citations across indexed works.

12h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
42companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

8940 N Kendall Dr
Suite 400e
Miami, FL 331762148

Telephone

305-598-2020

Registry record last updated 2 Jul 2012.

View the NPPES registry record

Industry payments

42 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    82.4%
    Antineovascularisation agents78.7%
    Faricimab-svoa100%
    Part B, office-administered≥26 patients
    Corticosteroid1.9%
    Prednisolone Acetate100%
    Part D≥125 patients

    + 4 more classes in this area

  • Cancer & immunology

    17.3%
    Vascular Endothelial Growth Factor Inhibitor17.3%
    Aflibercept96%Eylea4%
    Part D + Part B≥172 patients
  • Musculoskeletal

    0.4%
    Cyclooxygenase Inhibitor0.4%
    Ketorolac Tromethamine100%
    Part D≥19 patients
Where care is delivered (Part B)0.1% facility · 99.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”